Volume 13, Issue 3 (Autumn 2006)                   J Birjand Univ Med Sci. 2006, 13(3): 9-15 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharifi-Systani N, Sadeghian M, Homaei F, Haghighi F. Immunohistochemical study of cell proliferation marker (Ki-67), estrogen, and progesterone receptors expression in breast carcinoma . J Birjand Univ Med Sci.. 2006; 13 (3) :9-15
URL: http://journal.bums.ac.ir/article-1-101-en.html
1- Assistant Professor, Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran , n-sharifi@mums.ac.ir
2- Assistant Professor, Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3- Assistant Professor, Department of Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:   (25958 Views)
Background and Aim: Breast carcinoma is a pervasive malignancy in the world, and in our country-Iran-as well. Extensive studies have been done on its diagnostic and therapeutic procedures and factors affecting its prognosis. The present study aimed at determining proliferative rate of cells, the condition of steroid hormone receptors, correlation of these with each other and with other factors such as age ,lymph nodes involvement, and tumoral grade in breast carcinoma.
Materials and Methods: This analytical and applied study was carried out in the pathology laboratory of Ghaem hospital -affiliated to Mashhad University of Medical Sciences- in 2004. Fifty cases of breast carcinoma, confirmed through histopathology, were selected. After checking microscopic slides and preparing suitable sections, specific staining through immunohistochemical procedure with estrogen (ER), progesteron (PR) markers, and Ki-67 was done. Then the slides were examined by two pathologists to determine immunoreactivity of tumoral cells by means of H-score system for ER and PR, the percent of tumoral cells for Ki- 67, and then the results were reported. The obtained data was analysed at the significant level P≤0.05 applying ANOVA and Spearman correlation coefficient statistical tests.
Results: Ki-67, ER and PR expression in patients with invasive ductal carcinoma were 24.25%, 89.62 and 59 respectively. Between Ki-67 and ER no relationship was found. But there was a significant correlation between Ki-67 and PR (P=0.05). Also, there was a significant correlation between the incidence of ER and PR (P=0.00). Ki-67 expression in the three grades of invasive ductal breast carcinoma revealed distinct and meaningful difference (P=0.01). Among rare types of breast carcinomas, the most expression of Ki-67, PR and ER was observed in invasive lobular carcinoma and the least in papillary and medulary carcinomas.
Conclusion: Immunohistochemistry is very important in the prognosis and treatment of breast carcinoma. Thus proper procedures, standardization of ER and PR is necessary.
Full-Text [PDF 201 kb]   (2639 Downloads)    
Type of Study: Original Article | Subject: Histology
Received: 2006/09/6 | Accepted: 2016/03/10 | ePublished: 2016/03/10

Add your comments about this article : Your username or Email:

Send email to the article author

© 2021 All Rights Reserved | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb